These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Intravenous lisuride in the treatment of the neuroleptic malignant syndrome.
    Author: Sczesni B, Bittkau S, von Baumgarten F, von Schröder J, Suchy I, Przuntek H.
    Journal: J Clin Psychopharmacol; 1991 Jun; 11(3):185-8. PubMed ID: 2066456.
    Abstract:
    Four severe cases of the neuroleptic malignant syndrome (NMS) were successfully treated with intravenous infusion of the dopamine agonist lisuride in doses up to 0.25 mg per hour or 4.0 mg per day, respectively. Dramatic improvements of the clinical symptoms--in particular the extrapyramidal syndrome and state of consciousness-- could be observed in two cases. The pharmacological properties of intravenous lisuride seem to make it an alternative in the treatment of NMS, which merits further study.
    [Abstract] [Full Text] [Related] [New Search]